Open Comparative Study With a Cross-Over According to Patients'Preference Receiving Xeloda or UFT With Folinic Acid in Advanced or Metastatic Colo-Rectal Cancer.
Phase of Trial: Phase III
Latest Information Update: 20 Jul 2012
At a glance
- Drugs Capecitabine (Primary) ; Folinic acid (Primary) ; Tegafur/uracil (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms COLOCROSS
- 20 Jul 2012 Actual end date (1 Sep 2011) added as reported by ClinicalTrials.gov.
- 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov..